These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 210147)

  • 41. Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.
    Friedman MG; Leventon-Kriss S; Sarov I
    J Clin Microbiol; 1979 Jan; 9(1):1-10. PubMed ID: 219015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history.
    Fung LW; Lao TT; Suen SS; Chan OK; Lau TK; Ngai KL; Chan PK; Leung TY
    Vaccine; 2011 Oct; 29(46):8186-8. PubMed ID: 21911021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroprevalence of antibodies against varicella-zoster virus among prevalent hemodialysis patients.
    Talebi-Taher M; Hassanzadeh T; Ossareh S
    Iran J Kidney Dis; 2013 Nov; 7(6):475-8. PubMed ID: 24241094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The seroepidemiology of the varicella-zoster virus in children and adolescents].
    Gil Miguel A; Lasheras Lozano ML; Jiménez García R; Calle Purón ME; Santos Santos M; Rey Calero J; Martín Hernández D
    Aten Primaria; 1993 May; 11(8):416-8. PubMed ID: 8388262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varicella-zoster virus prevalence in Japan: no significant change in a decade.
    Taylor-Wiedeman J; Yamashita K; Miyamura K; Yamazaki S
    Jpn J Med Sci Biol; 1989 Feb; 42(1):1-11. PubMed ID: 2550689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.
    Davidovici BB; Balicer RD; Klement E; Green MS; Mendelson E; Smetana Z; Cohen DI
    Eur J Epidemiol; 2007; 22(9):641-6. PubMed ID: 17668279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definition of high-proficiency serological markers for diagnosis of varicella-zoster virus infections by enzyme immunoassay.
    Echevarría JM; de Ory F; León P; Téllez A
    J Med Virol; 1989 Mar; 27(3):224-30. PubMed ID: 2542432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroepidemiology of varicella-zoster virus in Bangladesh.
    Saha SK; Darmstadt GL; Hanif M; Khan R
    Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placental transfer and decay of varicella-zoster virus antibodies in preterm infants.
    Linder N; Waintraub I; Smetana Z; Barzilai A; Lubin D; Mendelson E; Sirota L
    J Pediatr; 2000 Jul; 137(1):85-9. PubMed ID: 10891827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Seroprevalence of varicella-zoster virus in children with cancer in six hospitals in Santiago, Chile].
    Izquierdo G; Zubieta M; Martínez G MJ; Alvarez AM; Aviles CL; Becker A; Peña M; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Santolaya ME;
    Rev Chilena Infectol; 2012 Dec; 29(6):595-9. PubMed ID: 23412026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus.
    Shigeta S; Baba M; Ogata M; Iijima S; Murai C
    Microbiol Immunol; 1981; 25(3):295-303. PubMed ID: 6166838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The age of infection with varicella-zoster virus in St Lucia, West Indies.
    Garnett GP; Cox MJ; Bundy DA; Didier JM; St Catharine J
    Epidemiol Infect; 1993 Apr; 110(2):361-72. PubMed ID: 8386097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women.
    Linder N; Ferber A; Kopilov U; Smetana Z; Barzilai A; Mendelson E; Sirota L
    Fetal Diagn Ther; 2001; 16(6):423-6. PubMed ID: 11694750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Asymptomatic varicella infections in pregnancy: detection and problems].
    Grüninger T; Dobec M; Keller A
    Gynakol Geburtshilfliche Rundsch; 1994; 34(3):171-4. PubMed ID: 7987086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults.
    Vyse AJ; Gay NJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Infect; 2004 Dec; 132(6):1129-34. PubMed ID: 15635971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A seroepidemiological study of varicella].
    Saito M; Haruyama C; Ohba H; Wada A; Takeuchi Y
    Kansenshogaku Zasshi; 1987 Jul; 61(7):783-8. PubMed ID: 2828485
    [No Abstract]   [Full Text] [Related]  

  • 59. Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay.
    Venkitaraman AR; Seigneurin JM; Baccard M; Lenoir GM; John TJ
    J Clin Microbiol; 1984 Sep; 20(3):582-3. PubMed ID: 6092431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of neutralization of Varicella-Zoster virus to antibody to immunoglobulin.
    Asano Y; Albrecht P; Stagno S; Takahashi M
    J Infect Dis; 1982 Oct; 146(4):524-9. PubMed ID: 6288808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.